Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editors: Phentermine/topiramate extended release is a novel medication approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese adults. To our knowledge, phentermine/topiramate extended release has not yet been evaluated in binge eating disorder, which often co-occurs with obesity. We therefore present 2 patients with binge eating disorder and obesity who experienced cessation of binge-eating behaviors and clinically significant weight loss with phentermine/topiramate extended release.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Please sign in or purchase this PDF for $40.00.